Literature DB >> 17277352

Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.

Yoav Michowitz1, Emil Goldstein, Dov Wexler, David Sheps, Gad Keren, Jacob George.   

Abstract

BACKGROUND: Circulating endothelial progenitor cells (EPCs) are increased in conditions associated with ischaemia and can potentially support angiogenesis and vasculogenesis. EPC levels were also shown to predict outcome in patients with atherosclerotic vascular disease. We tested the hypothesis that circulating EPC can predict outcome in patients with congestive heart failure (CHF).
METHODS: EPC-colony-forming units were measured in the peripheral blood of 107 consecutive patients with CHF with New York Heart Association (NYHA) functional class II-IV. Serum levels of vascular endothelial growth factor (VEGF), N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) and high-sensitivity C-reactive protein (hsCRP) were also measured. End points were defined as CHF-related hospital admissions and all-cause mortality.
RESULTS: Age (p = 0.01), diabetes mellitus (p = 0.002) and EPC levels (p = 0.02) were found to be independent predictors of all-cause mortality. EPC levels did not predict CHF-related hospitalisations. EPC levels correlated positively with NYHA (p = 0.05, r = 0.19), but did not correlate with VEGF, NT-pro-BNP or hsCRP. EPC levels did not differ by the aetiology of CHF.
CONCLUSIONS: EPC levels are independent predictors of all-cause mortality among patients with CHF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277352      PMCID: PMC1955007          DOI: 10.1136/hrt.2006.102657

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

1.  Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.

Authors:  M Vasa; S Fichtlscherer; A Aicher; K Adler; C Urbich; H Martin; A M Zeiher; S Dimmeler
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

2.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

3.  Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells.

Authors:  M Gill; S Dias; K Hattori; M L Rivera; D Hicklin; L Witte; L Girardi; R Yurt; H Himel; S Rafii
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

4.  Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.

Authors:  S Shintani; T Murohara; H Ikeda; T Ueno; T Honma; A Katoh; K Sasaki; T Shimada; Y Oike; T Imaizumi
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

5.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

Authors:  K A Jackson; S M Majka; H Wang; J Pocius; C J Hartley; M W Majesky; M L Entman; L H Michael; K K Hirschi; M A Goodell
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

Authors:  S Dimmeler; A Aicher; M Vasa; C Mildner-Rihm; K Adler; M Tiemann; H Rütten; S Fichtlscherer; H Martin; A M Zeiher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

7.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.

Authors:  Oren M Tepper; Robert D Galiano; Jennifer M Capla; Christoph Kalka; Paul J Gagne; Glen R Jacobowitz; Jamie P Levine; Geoffrey C Gurtner
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

9.  The prognostic importance of anemia in patients with heart failure.

Authors:  Mikhail Kosiborod; Grace L Smith; Martha J Radford; JoAnne M Foody; Harlan M Krumholz
Journal:  Am J Med       Date:  2003-02-01       Impact factor: 4.965

10.  Systolic and diastolic heart failure in the community.

Authors:  Francesca Bursi; Susan A Weston; Margaret M Redfield; Steven J Jacobsen; Serguei Pakhomov; Vuyisile T Nkomo; Ryan A Meverden; Véronique L Roger
Journal:  JAMA       Date:  2006-11-08       Impact factor: 56.272

View more
  25 in total

Review 1.  Resident vascular progenitor cells--diverse origins, phenotype, and function.

Authors:  Peter J Psaltis; Adriana Harbuzariu; Sinny Delacroix; Eric W Holroyd; Robert D Simari
Journal:  J Cardiovasc Transl Res       Date:  2010-11-30       Impact factor: 4.132

Review 2.  Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney disease?

Authors:  Rajesh Mohandas; Mark S Segal
Journal:  Blood Purif       Date:  2010-01-08       Impact factor: 2.614

Review 3.  Endothelial progenitor cells in cardiovascular diseases.

Authors:  Poay Sian Sabrina Lee; Kian Keong Poh
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

4.  Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.

Authors:  Nisha Bansal; Leila Zelnick; Zeenat Bhat; Mirela Dobre; Jiang He; James Lash; Bernard Jaar; Rupal Mehta; Dominic Raj; Hernan Rincon-Choles; Milda Saunders; Sarah Schrauben; Matthew Weir; Julie Wright; Alan S Go
Journal:  J Am Coll Cardiol       Date:  2019-06-04       Impact factor: 24.094

Review 5.  Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.

Authors:  Johannes C Grisar; Francois Haddad; Fatemeh A Gomari; Joseph C Wu
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

Review 6.  BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.

Authors:  Mark Oremus; Andrew Don-Wauchope; Robert McKelvie; Pasqualina L Santaguida; Stephen Hill; Cynthia Balion; Ronald Booth; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

7.  Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

Authors:  Ayman Samman Tahhan; Muhammad Hammadah; Pratik B Sandesara; Salim S Hayek; Andreas P Kalogeropoulos; Ayman Alkhoder; Heval Mohamed Kelli; Matthew Topel; Nima Ghasemzadeh; Kaavya Chivukula; Yi-An Ko; Hiroshi Aida; Iraj Hesaroieh; Ernestine Mahar; Jonathan H Kim; Peter Wilson; Leslee Shaw; Viola Vaccarino; Edmund K Waller; Arshed A Quyyumi
Journal:  Circ Heart Fail       Date:  2017-08-08       Impact factor: 8.790

8.  Tachycardia pacing induces myocardial neovascularization and mobilizes circulating endothelial progenitor cells partly via SDF-1 pathway in canines.

Authors:  Jingting Mai; Fei Wang; Qiong Qiu; Buzhou Tang; YongQing Lin; NianSang Luo; WoLiang Yuan; XiaoLong Wang; Qingcai Chen; JingFeng Wang; YangXin Chen
Journal:  Heart Vessels       Date:  2014-12-10       Impact factor: 2.037

9.  Endothelial progenitor cells: what use for the cardiologist?

Authors:  Aurangzeb Siddique; Eduard Shantsila; Gregory Yh Lip; Chetan Varma
Journal:  J Angiogenes Res       Date:  2010-02-22

Review 10.  Endothelial Progenitor Cells in Heart Failure: an Authentic Expectation for Potential Future Use and a Lack of Universal Definition.

Authors:  Andie H Djohan; Ching-Hui Sia; Poay Sian Lee; Kian-Keong Poh
Journal:  J Cardiovasc Transl Res       Date:  2018-05-17       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.